Long-term biochemical and virological response to natural interferon-α in patients with chronic hepatitis C

Digestive Diseases and Sciences

Volumn 41, Issue 5, 1996, Pages 1001-1007

  Hagiwara, Hideki ^b   Hayashi, Norio ^a   Kasahara, Akinori ^b   Oshita, Masahide ^b   Katayama, Kazuhiro ^b   Naito, Masafumi ^b   Masuzawa, Manabu ^b   Yoshihara, Harumasa ^b   Shimizu, Yoji ^b   Fusamoto, Hideyuki ^b   Kamada, Takenobu ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

chronic hepatitis C; hepatitis C virus RNA; interferon therapy; long term follow up study; long term outcome

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; ENDOGENOUS COMPOUND; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 9344225721     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02091544     Document Type: Article

References (34)

1. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, Waggoner JG, Park Y, Jones EA: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 315:1575-1578, 1986
2. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, VanThiel DH, Tanburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A: The hepatitis interventional therapy group. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 321:1501-1506, 1989
3. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH: Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 321:1506-1510, 1989
4. Di Bisceglie AM, Shindo M, Fong T-L, Fried MW, Swain MG, Bergasa NV, Axiotis CA, Waggoner JG, Park Y, Hoofnagle JH: A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 16:649-654, 1992
5. Kakumu S, Yoshioka K, Wakita T, Ishikawa I, Takayanagi M, Higashi Y: A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology 105:507-512, 1993
6. Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, Miglioli M, Barbara L: A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 107:812-817, 1994
7. Omata M, Ito Y, Yokosuka O, Imazeki F, Tagawa M, Takano S, Hosoda K, Tada M, Ohto M, Ito K, Okuda K: Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant α-interferon for chronic non-A, non-B hepatitis. Dig Dis Sci 36:1217-1222, 1991
8. Sáez-Royuela F, Porres JC, Moreno A, Castilio I, Martinez G, Galiana F, Carreño V. High doses of recombinant α-interferon or γ-interferon for chronic hepatitis C: A randomized, controlled trial. Hepatology 13:327-331, 1991
9. Marcellin P, Boyer N, Giostra E, Degott C, Courouce AM, Degos F, Coppere H, Cales P, Couzigou P, Benhamou JP: Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France. Hepatology 13:393-397, 1991
10. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, Heyraud JP, Fontanges T, Albrecht J, Meschievitz C, Trepo C: Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 101:497-502, 1991
11. Shindo M, Di Bisceglie AM, Cheung L, Shin JWK, Cristiano K, Feinstone SM, Hoofnagle JH: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 115:700-704, 1991
12. Hagiwara H, Hayashi N, Mita E, Ueda K, Takehara T, Kasahara A, Fusamoto H, Kamada T: Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α. Hepatology 15:37-41, 1992
13. Davis GL: Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol 21:1-3, 1994
14. Hagiwara H, Hayashi N, Mita H, Takehara T, Kasahara A, Fusumoto H, Kamada T: Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 104:877-883, 1993
15. Lau JYN, Davis GL, Kniffen J, Qian K-P, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC: Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504, 1993
16. Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S: The degree of variability in the amino terminal region of the E2/NSI protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16:619-624, 1992
17. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T: Detection of hepatitis C virus by polymerase chain reaction and response to interferon therapy: Relationship to genotypes of hepatitis C virus. Hepatology 16:293-299, 1992
18. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, Fusamoto H, Kamada T: Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci 39:977-982, 1994
19. Tsubota A, Chayama K, Ikeda K, Yusuji A, Kaida I, Saitoh S, Hashimoto M, Iwasaki S, Kobayashi M, Kumada H: Factors predictive of response to interferon-α therapy in hepatitis C virus infection. Hepatology 19:1088-1094, 1994
20. Kanazawa Y, Hayashi N, Mita E, Li T, Hagiwara H, Kasahara A, Fusamoto H, Kamada T: Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 20:1121-1130, 1994
21. Moribe T, Hayashi N, Kanazawa Y, Mita E, Fusamoto H, Negi M, Kaneshige T, Igimi H, Kamada T, Uchida K: Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 108:789-795, 1995
22. Pagliaro L, Craxí A, Cammaá C, Tiné F, Di Marco V, Lo Iacono O, Almasio P. Interferon-α for chronic hepatitis C: An analysis of pretreatment clinical predictors of response. Hepatology 19:820-828, 1994
23. Jouët P, Roudot-Thoraval F, Dhumeaux D, Métreau J-M, Le Groupe Fraca̧is pour l'Etude du Traitement des Hépatites Chroniques NANB/C: Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology 106:686-690, 1994
24. Carreño V, Bartolomé J, Castillo I: Long-term effect of interferon therapy in chronic hepatitis B. J Hepatol 20:431-435, 1994
25. Lok ASF, Chung H-T, Liu VWS, Ma OCK: Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. Gastroenterology 105:1833-1838, 1993
26. Shindo M, Di Bisceglie AM, Hoofnagle JH: Long-term follow-up of patients with chronic hepatitis C treated with α-interferon. Hepatology 15:1013-1016, 1992
27. Kasahara A, Hayashi N, Hiramatsu N, Oshita M, Hagiwara H, Katayama K, Kato M, Masuzawa M, Yoshihara H, Kishida Y, Shimizu Y, Inoue A, Fusamoto H, Kamada T: Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial. Hepatology 21:291-297, 1995
28. Hagiwara H, Hayashi N, Mita E, Hiramatsu N, Ueda K, Takehara T, Yuki N, Kasahara A, Fusamoto H, Kamada T: Detection of hepatitis C virus RNA in chronic non-A, non-B liver disease. Gastroenterology 102:692-694, 1992
29. Hagiwara H, Hayashi N, Mita E, Naito M, Kasahara A, Fusamoto H, Kamada T: Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 17:545-550, 1993
30. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679, 1992
31. Castillo I, Bartolomé J, Navas S, Gonzalez S, Herrero M, Carreño V: Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon. Hepatology 19:1342-1346, 1994
32. Marcellin P, Boyer N, Degott C, Martinot-Peignoux M, Duchatelle V, Giostra E, Areias J, Erlinger S, Benhamou J-P: Long-term histologic and viral changes in patients with chronic-hepatitis C who responded to alpha interferon. Liver 14:302-307, 1994
33. 2b. Hepatology 18:1300-1305, 1993
34. Kanto T, Hayashi N, Takehara T, Hagiwara H, Mita E, Oshita M, Katayama K, Kasahara A, Fusamoto H, Kamada T: Serial density analysis of hepatitis C virus particle populations in chronic hepatitis C patients treated with interferon-α. J Med Virol 46:230-237, 1995